Name | SP-2-225 |
---|
Description | SP-2-225 is a selective HDAC6 inhibitor. SP-2-225 enhance the production of cancer-associated antigens and macrophage antigen cross-presentation to T cells. SP-2-225 reduces the tumor volume in a syngeneic SM1 melanoma model[1]. |
---|---|
Related Catalog | |
Target |
HDAC6[1] |
References |
Molecular Formula | C28H34N2O3 |
---|---|
Molecular Weight | 446.58 |